Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

July 10, 2025

Simcere Pharmaceutical seeks China approval for atopic dermatitis treatment

Connect Biopharma announced that its collaborator and exclusive licensee, Simcere Pharmaceutical has submitted a New Drug Application (NDA) for rademikibart to China's National Medical Products Administration (NMPA).

Simcere Pharmaceutical seeks China approval for atopic dermatitis treatment